Trabeculotomy in a Behçet’s Disease Patient One Week after Infliximab Administration

Purpose: To describe a patient with Behçet’s disease and anterior uveitis, which was not cured by local and systemic corticosteroid treatments, who underwent trabeculotomy one week after infliximab administration. Methods: The patient received preoperative antibiotic therapy followed by trabeculotom...

Full description

Saved in:
Bibliographic Details
Published inCase reports in ophthalmology Vol. 3; no. 1; pp. 151 - 155
Main Authors Koike, Aya, Handa, Tsuneaki, Zako, Masahiro
Format Journal Article
LanguageEnglish
Published Basel, Switzerland S. Karger AG 30.04.2012
Karger Publishers
Subjects
Behçet’s disease
Infection
Infliximab
Published: April 2012
Trabeculotomy
Tumor necrosis factor-alpha
Infection
Trabeculotomy
Tumor necrosis factor-alpha
Infliximab
Behçet’s disease
Behçet's disease
Online AccessGet full text

Cover

More Information
Summary:Purpose: To describe a patient with Behçet’s disease and anterior uveitis, which was not cured by local and systemic corticosteroid treatments, who underwent trabeculotomy one week after infliximab administration. Methods: The patient received preoperative antibiotic therapy followed by trabeculotomy one week after infliximab administration. We observed ocular findings before and after surgery. Results: Anterior uveitis improved after infliximab administration. The elevated intraocular pressure improved after surgery and there were no intraoperative complications. Neither ocular inflammatory attacks nor infectious complications were found in the operated eye of the patient during follow-up. Conclusion: Trabeculotomy one week after administration of infliximab appears to be safe and effective in treating secondary glaucoma associated with Behçet’s disease.
ISSN:1663-2699
1663-2699
DOI:10.1159/000338703